PubMed Health⌕ Search

PubMed · 12401457

Plantar response in infancy.

Abstract

The objective of the study was to characterize the plantar response at various ages in infancy in Indian children. The subjects were 1281 apparently healthy children born at term and without any history suggestive of neurological disease, enrolled between the ages of 1 and 12 months. The plantar response was elicited in both feet by thumbnail drag method and graded as flexor, extensor and equivocal. The percentage of extensor, flexor and equivocal responses was compared between right and left foot and the average of these two responses was compared between the age categories [1-3 months (n=389), 3.1-6 months (n=332), 6.1-9 months (n=354) and 9.1-12 months (n=206)]. Frequency (%) of various combinations of bilateral responses was also calculated for different age categories. Results showed that the extensor plantar response was the predominant response till 6 months of age. Bilateral extensor response was seen in 79.4%, 67.8%, 32.5% and 31.1% in the four age categories respectively; bilateral flexor response in the corresponding age groups was 0.3%, 5.1%, 26.6% and 39.3% respectively. The percentage of asymmetrical responses was 20.7%, 25.3%, 40.3%, and 28.7% in different age categories. We concluded that normal plantar response is predominantly extensor in early infancy; the transition to flexor response starts occurring after 6 months of age. A fairly high number of infants continue to have an extensor response even after 6 months; and the transition may be advanced in one foot leading to asymmetrical plantar response.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ghanshyam D Kumhar, Tarun Dua, Piyush Gupta. 2002. Plantar response in infancy.. https://doi.org/10.1016/s1090-3798(02)90620-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗